These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35963634)

  • 1. Safety of Statins and Nonstatins for Treatment of Dyslipidemia.
    Newman CB
    Endocrinol Metab Clin North Am; 2022 Sep; 51(3):655-679. PubMed ID: 35963634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combinations of statins and fibrates: pharmacokinetic and clinical implications].
    González Santos P
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():7-11. PubMed ID: 25043540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins, myalgia, and rhabdomyolysis.
    Tournadre A
    Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrates in combination with statins in the management of dyslipidemia.
    Jacobson TA; Zimmerman FH
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1):35-41; quiz 42-3. PubMed ID: 16407687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Associated Muscular Adverse Effects.
    Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
    Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH; Zakowski LJ; McBride PE
    WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Dyslipidemia: Epidemiology and Prevention of Cardiovascular Disease and Implications of Newer Therapies.
    Warraich HJ; Rana JS
    Curr Cardiol Rep; 2018 Oct; 20(12):125. PubMed ID: 30311078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing the underestimated risk of statin-associated myopathy.
    Rallidis LS; Fountoulaki K; Anastasiou-Nana M
    Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
    Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
    Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies.
    Schwier NC; Cornelio CK; Boylan PM
    Pharmacotherapy; 2022 Apr; 42(4):320-333. PubMed ID: 35175631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS; Milionis HJ; Elisaf MS
    Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbrella Review on Non-Statin Lipid-Lowering Therapy.
    Beshir SA; Hussain N; Elnor AA; Said ASA
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):437-452. PubMed ID: 33836639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.